Article Data

  • Views 553
  • Dowloads 152

Original Research

Open Access

Clinical analysis of forty-one multicentric lesions of female lower genital tract

  • Ying Han1
  • Ling-ying Wu1,*,
  • Shu-min Li1
  • Rong Zhang1
  • Ping Bai1
  • Yang-chun Sun1
  • Ning Li1
  • Jing Zhang1

1National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing (China)

DOI: 0.12892/ejgo3667.2018 Vol.39,Issue 1,February 2018 pp.128-132

Published: 10 February 2018

*Corresponding Author(s): Ling-ying Wu E-mail: wulingying@csco.org.cn

Abstract

Objectives: To observe the clinical characteristics of multicentric lesions of lower genital tract. Materials and Methods: A retrospective review of 41 multicentric dysplasia treated in the present hospital from January 2000 to July 2015 was conducted. Multicentric lesions included two or three lesions of cervical intraepithelial neoplasia (CIN), vaginal intraepithelial neoplasia (VAIN), and vulvar intraepithelial neoplasia (VIN). Results: Forty-one patients presented multicentric lesions out of 2,238 patients referred for CIN (1.8%). The average age was 53.6 years. The average number of pregnancies was two (range, one to four). Immunologic disorders were presented in 15/41 (36.6%) patients and 92.7% (38/41) patients had cervico-vaginal or had cervico-vulvar lesions, and one had vaginal and vulvar lesions. Only 4.9% (2/41) had three sites of genital lesions at the same time. 77.5% (31/40) of CIN were high grade (CIN III or microinvasive lesion or carcinamoa in situ), 70.97% (22/31) of VAIN were high grade (VAIN III), and 84.6% (11/13) of VIN were high grade (VIN III). Therapeutic modalities included surgery (conization, vagina lesions resection, hysterectomy, vulvectomy) and non-surgical procedures (cervical fulgurize, intracavitary brachytherapy, and 5-fluorouracil local application). Thirty-eight patients were followed- up and had at least one post-treatment cytological control; 15.8% (6/38) had residual disease. Out of the 38 patients followed-up for more than three months, 32 patients had at least two negative controls after treatment (84.2%) and five of them had recurrence. Conclusion: Multicentric lesions of female lower genital tract are associated with HPV infection, and the lesions are always multicentric and locally multipoint. Appropriate treatments could reduce the rate of residual lesion and recurrence.


Keywords

Multicentric dysplasia; Lower genital tract; CIN; VAIN; VIN; HPV.

Cite and Share

Ying Han,Ling-ying Wu,Shu-min Li,Rong Zhang,Ping Bai,Yang-chun Sun,Ning Li,Jing Zhang. Clinical analysis of forty-one multicentric lesions of female lower genital tract. European Journal of Gynaecological Oncology. 2018. 39(1);128-132.

References

[1] Gormley RH, Kovarik CL. Human papillomavirus-related genital disease in the immunocompromised host: Part I. J. Am. Acad. Dermatol., 2012, 66, 867.

[2] Miklos P., Babala P., Klacko M., Masak L., Ondrus D.: “Vulvar intraepithelial neoplasia”. Klin. Onkol., 2011, 24, 50.

[3] Feng Q., Kiviat N.B.: “New and surprising insights into pathogenesis of multicentric squamous cancers in the female lower genital tract”. J. Natl. Cancer Inst., 2005, 97, 1798.

[4] Marcus S.L.: “Multiple squamous cell carcinomas involving the cervix,vagina,and vulva: the theory of multicentric origin”. Am. J. Obstet. Gynecol., 1960, 80, 802.

[5] Menguellet S.A., Collinet P., Debarge V.H., NayamaM., Vinatier D., Leroy J.L.: “Management of multicentric lesions of the lower genital tract”. Eur. J. Obstet. Gynecol/ Reprod. Biol., 2007, 132, 116.

[6] Dodge J.A., Eltabbakh G.H., Mount S.L., Walker R.P., Morgan A.: “Clinical features and risk of recurrence among patients with vaginal intraepithelial neoplasia”. Gynecol. Oncol., 2001, 83, 363.

[7] Bornstein J., Kaufman R.H., Adam E., Adler-Storthz K.: “Multicentric intraepithelial neoplasia involving the vulva. Clinical features and association with human papillomavirus and herpes simplex virus”. Cancer, 1988, 62, 1601.

[8] Thuis Y.N., Campion M., Fox H., Hacker N.F.: “Contemporary experience with the management of vulvar intraepithelial neoplasia”. Int. J. Gynecol. Cancer, 2000, 10, 223.

[9] Hampl M., Wentzensen N., Vinokurova S., Von Knebel-Doeberitz M., Poremba C., Bender H.G., Kueppers V.: “Comprehensive analysis of 130 multicentric intraepithelial female lower genital tract lesions by HPV typing and p16 expression profile”. J. Cancer Res. Clin. Oncol., 2007, 133, 235.

[10] Hording U., Daugaard S., Junge J., Lundvall F.: “Human papillomaviruses and multifocal genital neoplasia”. Int. J. Gynecol. Pathol., 1996, 15, 230.

[11] Vinokurova S., Wentzensen N., Einenkel J., Klaes R., Ziegert C., Melsheimer P., et al.: “Clonal history of papillomavirus-induced dysplasia in the female lower genital tract”. J. Natl. Cancer. Inst., 2005, 97, 1816.

[12] Dodge J.A., Eltabbakh G.H., Mount S.L., Walker R.P., Morgan A.: “Clinical features and risk of recurrence among patients with vaginal intraepithelial neoplasia”. Gynecol. Oncol., 2001, 83, 363.

[13] Stanley M.: “Genital human papillomavirus infections—current and prospective therapies”. J. Natl. Cancer Inst. Monogr., 2003, 31, 117.

[14] Nappi L., Carriero C., Bettocchi S., Herrero J., Vimercati A., Putignano G.: “Cervical squamous intraepithelial lesions of low-grade in HIV-infected women: recurrence, persistence, and progression, in treated and untreated women”. Eur. J. Obstet. Gynecol. Reprod. Biol., 2005, 121, 226.

[15] Iavazzo C., Pitsouni E., Athanasiou S., Falagas M.E.: “Imiquimod for treatment of vulvar and vaginal intraepithelial neoplasia”. Int. J. Gynecol. Obstet., 2008, 101, 3.

[16] Stentella P., Frega A., Ciccarone M., Cipriano L., Tinari A., Tzantzoglou S., Pachì A.: “HPV and intraepithelial neoplasia recurrent lesions of the lower genital tract: assessment of the immune system”. Eur. J. Gynaecol. Oncol., 1998, 19, 466.

[17] “Committee Opinion No. 641: “Human Papillomavirus Vaccination”. Obstet. Gynecol., 2015, 126, e38.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time

Conferences

Top